A key to healthy aging? New study says you should load up on these kinds of carbs.
Women who eat more fiber and high-quality carbohydrates in midlife are more likely to be cognitively and physically healthy in their old age, a large new study suggests.
While there's a lot of evidence showing how diet affects longevity and the risk for chronic diseases, the new study focused on how what we eat influences quality of life as we age, according to the report published in JAMA Network Open.
Researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, analyzed diet data from 47,512 women who were participants of the long-running Nurses' Health Study, one of the most respected and largest investigations into causes of chronic diseases in women.
Every four years, between 1984 and 2016, the participants filled out a questionnaire that asked how frequently 130 foods had been consumed over the past year. The options ranged from never to six times a day.
The researchers centered on dietary data collected in 1984 and 1986, as this was when the women were at midlife.
'The primary high-quality carbohydrates were whole grains, whole fruits and vegetables and legumes,' scientist Andres Ardisson Korat, lead author of the new research, said. 'The reason is they have a lot of fiber and a lot more resistant forms of starches that break down more slowly in our bodies. Low quality carbohydrates included refined grains and added sugars.'
Resistant forms of starch, such as beans and legumes and whole grain, don't cause blood glucose levels to spike, plus they increase the feeling of fullness and are high in fiber.
The researchers defined healthy aging as surviving to age 70 while being free of 11 major chronic diseases, including cancer, diabetes, stroke, arthritis and osteoporosis; having no impairment in memory or physical function; and being in good mental health.
The dietary analysis revealed a 31% greater likelihood of healthy aging among women who ate high-quality carbs, while a diet heavy in low-quality carbs was associated with a 13% lower likelihood of healthy aging.
Ardisson Korat said healthy aging is someone with a positive score in four areas:
No major chronic disease.
Good physical health.
Good cognitive function.
Good mental health.
'A person with good physical health, for example, would be able to lift and carry groceries, climb a flight of stairs and walk a certain distance,' Ardisson Korat said.
Among the participants in the new study, only 3,706 reached age 70 free of chronic diseases. Ardisson Korat was surprised that so few women accomplished it, but noted a 2024 Tufts study on women's consumption of protein showed similar findings. In Ardisson Korat's protein research, women who ate more plant proteins were 46% more likely to be healthy into their later years, while women who ate more animal protein, such as beef, chicken, milk, fish and cheese were 6% less likely to stay healthy as they aged.
A limitation of the new study is that it didn't explore how high-quality carbohydrates could lead to a healthier old age. Also, the participants in the Nurses Health Study are mostly white women and the findings may not be representative of the broader population.
It's significant, however, because the researchers looked at how diet can have an impact on overall healthy aging, experts said.
Brooke Aggarwal, an associate professor of medical sciences in the division of cardiology at the Columbia University Vagelos College of Physicians and Surgeons, said the researchers focused on a really critical period in women's lives to suggest intervention.
'This shows with better attention to diet we might have a good quality of life: Can someone think clearly? Can they physically function well? Can they get in and out of bed by themselves,' Aggarwal said.
Other studies have shown that diets high in fiber can have a positive impact on outcomes, such as diabetes and other chronic diseases, said Dr. Gül Bahtiyar, chief of the division of endocrinology, diabetes and metabolism at NYC Health+Hospitals/Woodhull.
But a strength of the study is that it is 'huge,' said Bahtiyar, who was not involved in the research.
Heidi Silver, director of the Vanderbilt Diet, Body Composition, and Human Metabolism Core at the Vanderbilt University Medical Center, said the data in the new study showed that fruit was especially good for healthy aging.
'Fruits are a good source of vitamins and minerals,' said Silver, who was not involved in the research. 'There's such as wide range of micro nutrients in them. You don't get that from a lot of the other food groups.'
If people want to eat healthier, what would Silver suggest?
'I would recommend eating a variety of fruits,' she said. 'But they should at least eat two pieces of fruit a day.'
This article was originally published on NBCNews.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 hours ago
- Yahoo
Trump cuts threaten ‘irreplaceable' Harvard stockpile of human feces, urine
Kept frozen by liquid nitrogen inside laboratories at Harvard University are more than 1.5 million biospecimens that have mere 'weeks' left until they spoil. As Harvard fights the Trump administration in court over the suspension of nearly $3 billion in federal funding, soon there won't be enough money left to keep the freezers running. The nearly 50 years of collected human feces, urine, blood, tumors and even toenail clippings could have consequential implications for the future health of Americans, and yet, they're at risk of being lost if funding slashed by the Trump administration isn't restored. The mother lode collection housed at Harvard has supported generations-long chronic disease risk studies that have fundamentally shaped major scientific and medical advancements. Read more: Funding cuts, lawsuits, foreign students: The latest on Trump's war with Harvard University The studies have lead to major breakthroughs, including links between cigarettes and cardiovascular disease and alcohol consumption and breast cancer. The research also uncovered the dangers of trans fats, which the U.S. has now largely restricted. The biological samples collected during the studies are 'irreplaceable,' according to Walter Willett, a professor of epidemiology and nutrition at the Harvard T.H. Chan School of Public Health and one of the most sought-after nutritionists internationally. And some of the study participants could even die before the next check-in period, he said. 'No other institution in the world has this data,' Willett wrote in a May 30 court affidavit detailing the impacts of federal funding cuts on his research. Read more: Over 12,000 Harvard alums lend weight to court battle with Trump in new filing The money can't be replaced with private funding, Willett said, and Harvard has told him it won't be able to supplement lost dollars. Willett filed his affidavit last month as part of a lawsuit in which Harvard faculty members are suing the Trump administration. President Donald Trump has gone after the world's wealthiest higher education institution and its funding in the name of antisemitism, claiming Harvard has failed to protect Jewish students, particularly in the wake of the war in Gaza. Willett's research is funded by two federal grants from the National Cancer Institute at the National Institutes of Health. On May 6, he was informed the funding had been terminated for both the Nurses' Health Study and Health Professionals Follow-Up Study. The Nurses' Health Study, which began with its first installment in 1976, followed by Willett's involvement in 1989, started tracking a cohort of 116,000 women in order to understand how 'diets and lifestyle relate to the risk of developing cancer,' Willett's affidavit said. In addition to collected biological samples, much of the data comes from questionnaires filled out by study participants every two years. The Nurses' Health Study has associated circulating sex hormones and postmenopausal breast cancer risk; connected higher vitamin D levels linked with lower risks of both colon polyps and colon cancer; and played a role in discovering genetic variations involved in cancers and cancer-related factors. The Health Professionals Follow-up Study is parallel research that has been tracking the diets of 52,000 adult men who have been diagnosed with cancer from all states in America. 'This study collects data about heart attacks, cancer and other conditions that share risk factors with heart disease, such as dementia and Parkinson's disease,' Willett wrote. 'Dozens of other grants studying many diseases have used the dataset collected by this study.' Read more: 'We are not just fighting for Harvard': For alums, this year feels different The male-focused study, which has also been used for women's research, has unearthed the harmful effects of trans fat; made connections between healthy plant foods and lower cardiovascular risk; linked dietary patterns and prostate cancer risk; and associated olive oil benefits with a lower risk of dying from dementia. There is another element of urgency in addition to the uncertain future of the biological samples: Willett says some participants may die before researchers are able to follow up with them next year for new information on their physical and cognitive functions. 'The termination of my grants thus jeopardizes our chance to collect data from the living study participants who have voluntarily contributed personal information over the last four decades,' Willett wrote. 'This would deprive all Americans from the benefits of knowledge about diet, other aspects of lifestyle, and use of medications that enhance their possibilities of living longer and healthier lives.' Since April, the Trump administration has launched a series of attacks against Harvard. Nearly $3 billion in federal funding has either been cut or frozen, and there was also a wave of federal research grant terminations. The Harvard T. H. Chan School of Public Health announced in April that it was facing a 'significant budget crisis' resulting in layoffs and the non-renewal of two building leases. Since then, every one of the school's direct federal grants have been terminated and the school has even taken to social media to ask for donations. Federal funding makes up 46% of Harvard Chan School's budget. Read more: All Ivy League schools are supporting Harvard lawsuit — except these 2 U.S. Education Secretary Linda McMahon has also told the institution that the federal government would be barring Harvard University from acquiring new federal grants while the university continues to refuse to comply with the administration's demands for change on its campus. Harvard President Alan Garber wrote in a letter to U.S. Secretary of Education Linda McMahon that they share the same 'common ground,' but the university 'will not surrender its core, legally-protected principles out of fear.' Read more: Funding cuts, lawsuits, foreign students: The latest on Trump's war with Harvard University Garber pushed back on the administration via a lawsuit in April. Harvard argues that its constitutional rights have been violated by the government's threats to pull billions of dollars in funding if the school doesn't comply with demands for an overhaul. Following a further $450 million in announced cuts, the university amended its lawsuit. 'No government — regardless of which party is in power — should dictate what private universities can teach, whom they can admit and hire, and which areas of study and inquiry they can pursue,' the suit reads. Due to the federal cuts, Harvard announced that it has committing $250 million of 'central funding' to support research impacted by suspended and canceled federal grants. All Ivy League schools are supporting Harvard lawsuit — except these 2 Embassies directed to resume processing Harvard University student visas Over 12,000 Harvard alums lend weight to court battle with Trump in new filing 'We are not just fighting for Harvard': For alums, this year feels different What a monk, a librarian and a dentist have to do with Harvard's fight with Trump Read the original article on MassLive.
Yahoo
16 hours ago
- Yahoo
Dementia Risk Declining With Each Generation, Says Promising New Study
Dementia cases are on the rise around the world. In 2021, 57 million people were living with one of the neurodegenerative diseases under the dementia umbrella, and by 2050, that number is expected to reach 153 million. But a new study suggests the tides may be turning, with younger generations facing lower risks for the disease as they age. The research team, led by economist Xiaoxue Dou from the University of Queensland in Australia, ran a cross-sectional observational study using health survey data from the US, Europe and England: one that's representative of cross-sections of the populations involved at a single point in time, and based on observational data. The researchers only used variables that were available across all the survey data to estimate participants' dementia status, to compensate for any missing observations. "Birth cohorts born more recently were less likely to develop dementia in all three regions, albeit at different rates," the authors state in a journal article. "This decreasing trend was more pronounced among women than men." They particularly focused on people aged 71 years or older, with the data sorted into age groups spanning four years. Compared with the older groups, younger cohorts had lower age-specific dementia prevalence rates: 21.2 percent for those in the US study; 38.9 percent in the European study; and 28.3 percent in England. "For example, in the US, among people aged 81 to 85, 25.1 percent of those born between 1890-1913 had dementia, compared to 15.5 percent of those born between 1939-1943," economist and co-author Sabrina Lenzen of the University of Queensland told Nicola Davis at The Guardian. The team cautions their data may not accurately reflect what is happening in minority groups. But the findings suggest that, while aging populations globally will probably mean greater numbers of people living with dementia, the percentage of people affected may actually be decreasing, at least among the groups studied. This generational decrease in dementia risk, the study's authors write, "has important implications for health care planning, long-term care policies, and workforce requirements in aging populations." This research was published in JAMA Network Open. Several Psychiatric Disorders Share The Same Root Cause, Study Finds New Smart Dental Floss Can Detect Your Stress From Saliva Gluten Intolerance vs Celiac Disease: Experts Reveal The Key Differences


Medscape
a day ago
- Medscape
UK Valproate Restrictions in Men Justified? New Data
A large Danish cohort study showed no significant increase in neurodevelopmental disorders (NDDs) among children fathered by men taking valproate during spermatogenesis, challenging earlier safety concerns and current UK restrictions on valproate use in men. As previously reported by Medscape Medical News , the decision to restrict the drug in women and in men younger than 55 years was made in January 2024, after the UK Medicines and Healthcare products Regulatory Agency issued new guidance on the drug's use. 'Paternal exposure to antiseizure medication in association with conception is unlikely to pose any major risk for the offspring,' the investigators led by Jakob Christensen, DrMedSci, consultant neurologist at Aarhus University Hospital and professor at Aarhus University, Aarhus, Denmark, noted. The study was published online on May 22 in JAMA Network Open . Unnecessary Precaution? In the US and Europe, there is strong guidance about avoiding valproate in pregnant women and women of childbearing age due to an elevated risk for birth defects and other developmental problems. In January 2024, the European Medicines Agency's (EMA's) safety committee (Pharmacovigilance Risk Assessment Committee [PRAC]) expanded precautionary measures on valproate use to men considering fatherhood. The advisory was fueled largely by an observational study by the contract research organization IQVIA. The study showed that about 5 out of 100 children had an NDD when born to fathers taking valproate during the 3 months before conception compared with about 3 out of 100 when born to fathers treated with lamotrigine or levetiracetam. Last summer, Christensen and colleagues were unable to replicate the IQVIA results in a study using a subset of the same IQVIA data. However, at the time, only limited information about the IQVIA study was publicly available. Once additional information from the IQVIA study became available, the researchers tried again to replicate the findings, aligning their methods more closely with the IQVIA study. Despite using the same methodology and incorporating additional data, they were still unable to replicate the IQVIA findings. Their conclusion remained unchanged — there was no statistically significant increased risk for NDDs. Specifically, among 961 children exposed to paternal valproate monotherapy and 1401 exposed to lamotrigine or levetiracetam, there was no significant increase in risk for NDDs (adjusted hazard ratio [aHR], 1.02; 95% CI, 0.67-1.54). 'This finding remained robust across analyses of specific NDDs, analyses of valproate dose, analyses accounting for time trends, analyses allowing for polytherapy, analyses expanding the definition of NDDs, analyses restricted to fathers with epilepsy, and analyses with a restricted exposure window,' Christensen and colleagues reported. Restricting analyses to fathers with epilepsy of unknown cause yielded a higher risk (aHR, 2.48; 95% CI, 1.13-5.44), but this association was no longer significant in analyses matched on birth year (aHR, 2.33; 95% CI, 1.00-5.44). Additional sensitivity analyses (restricting exposure window, excluding children with epilepsy or maternal epilepsy, and accounting for polytherapy) consistently showed no elevated risk for NDDs associated with paternal valproate exposure. 'We've examined this issue from many angles and still find no evidence supporting the concern behind EMA's recommendations,' Christensen said in a news release. Will the EMA Reconsider? Reached for comment, Aatif Husain, MD, epileptologist, neurologist, and sleep medicine specialist at DukeHealth, Durham, North Carolina, said, 'There seems to be a fair amount of literature' suggesting no increased risk for NDDs in children whose fathers use valproate. 'A recent systematic review that included 10 other studies came to this same conclusion,' said Husain, who wasn't involved in the Danish study. Taken together, the data 'would probably move EMA to relook at their guidance to see if it needs to be modified,' he said. Medscape Medical News reached out to the EMA press office for comment and received the following response. 'As with every medicine authorized in the EU, EMA continues monitoring and supervising the safety of these medicines. This includes monitoring information from various sources, such as spontaneous reports, clinical studies, scientific literature, and management of safety signals, which consists of a set of activities to determine whether there are new risks associated with an active substance or a medicine or whether known risks have changed. Should there be any updates, EMA will communicate them via the PRAC Highlights.' Husain told Medscape Medical News that neither the FDA nor the American Epilepsy Society has issued guidance on valproate use in men 'because the data has not been strong enough.'